Antibody Arrays Identify Potential Diagnostic Markers of Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is the third leading cause of cancer deaths worldwide. Effective treatment of HCC patients is hampered by the lack of sensitive and specific diagnostic markers of HCC. Alpha-fetoprotein (AFP), the currently used HCC marker, misses 30%-50% of HCC patients, who therefore...
Main Authors: | Hongbo Sun, Mei-Sze Chua, Dorothy Yang, Anya Tsalenko, Brian J. Peter, Samuel So |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2008-01-01
|
Series: | Biomarker Insights |
Online Access: | https://doi.org/10.4137/BMI.S595 |
Similar Items
-
Antibody Arrays Identify Potential Diagnostic Markers of Hepatocellular Carcinoma
by: Brian J. Peter, et al.
Published: (2008-01-01) -
Diagnostic and Prognostic Molecular Markers in Hepatocellular Carcinoma
by: Beatriz Mínguez, et al.
Published: (2011-01-01) -
Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells
by: Grepper Susan, et al.
Published: (2009-09-01) -
Soluble Frizzled-7 receptor inhibits Wnt signaling and sensitizes hepatocellular carcinoma cells towards doxorubicin
by: Grepper Susan, et al.
Published: (2011-02-01) -
Development of IGF signaling antibody arrays for the identification of hepatocellular carcinoma biomarkers.
by: Qi Zhou, et al.
Published: (2012-01-01)